RENO, Nev., Sept. 19, 2011 /PRNewswire/ -- Visual Healthcare
Corp. (the "Company") (PINKSHEETS: VSHC) announces that it has
published its year-end disclosure statement and financial results.
These are available on the OTC Markets site as well as on the
company website at www.visualhealthcarecorp.com.
The Company is pleased to report that its 4th Quarter results
and year-end have been a major turnaround as the Company moves
toward establishing a stable position within the global Healthcare
IT marketplace.
Revenues were significantly up for fiscal year 2011 at
$2,093,104, with net income of
$30,291, both spurred largely by the
impact of current U.S. Administration's healthcare policies on the
marketplace.
"We have had a large increase in demand for our products in the
past year as healthcare reform has taken hold in earnest," says CEO
Gerard Dab. "We expect to continue
to grow revenues by adding new technologies to our portfolio, and
continue to license our platforms and software to an increasingly
large stable of licensees and will likely maintain our growth rate
for the next few years."
There will be a conference call for analysts to discuss company
results and prospects next Wednesday,
September 21st, 2001 at 1PM
EDT (New York time) to be
hosted by company Chairman Gerard
Dab. The following are the dial in and access numbers:
Dial-in number is (209) 647-1000. Access code is 910071.
Members of the public are welcome.
The full disclosure document and detailed financial statements
and results can be found at
http://www.otcmarkets.com/financialReportViewer?symbol=VSHC&id=60642
ABOUT VISUAL HEALTHCARE
Visual Healthcare Corp., since 1998, designs, creates and
develops innovative information platforms, specifically conceived
for the automation of a wide range of scientific disciplines. These
include pharmaceutical research, clinical trials, laboratory
automation, true quality assurance tools, total quality control
applications. They also include quantitative analytic tools
such as proprietary frameworks for electronic health records,
electronic prescription, infection and disease control, and smart
cancer registries. The company's extensive portfolio of proprietary
technologies is the result of a unique collaboration between senior
clinicians from the McGill University
Faculty of Medicine and affiliated tertiary care centers, medical
software architects, and a Fortune 100 healthcare service company,
investing some $50 million in the
process. The Company licenses its technology to operating companies
in exchange for an equity stake or a royalty stream. It owns
significant stakes in various companies including VisualMED
Clinical Solutions Corp. (PINKSHEETS: VMCS), a leader in the field
of smart electronic health records.
For more information, please visit:
www.visualhealthcarecorp.com.
FORWARD- LOOKING STATEMENTS
Except for historical information provided herein, this press
release may contain information and statements of a forward-looking
nature concerning the future performance of the Company. These
statements are based on suppositions and uncertainties as well as
on management's best possible evaluation of future events. Such
factors may include, without excluding other considerations,
fluctuations in quarterly results, evolution in customer demand for
the Company's products and services, the impact of price pressures
exerted by competitors, and general market trends or economic
changes. As a result, readers are advised that actual results may
differ from expected results.
Contact:
Gerard Dab, CEO
Visual Healthcare Corp.
514-582-5220
SOURCE Visual Healthcare Corp.